Slide 1: Higher sales, strong cash flow and new products creating more customer value
Higher sales, strong cash flow and new products creating more customer value Getinge Q1 2024 Mattias Perjos, CEO Agneta Palmér, CFO
Slide 2: Key takeaways Q1 2024
Key takeaways Q1 2024 • Net sales increased by 5.2% whereof 0.0% organically and order intake grew by 7.8% whereof 2.5% organically • Margins negatively impacted by quality related costs and higher costs for employees and input materials • Strengthened Free Cash Flow and solid financial position 34,
Slide 3: Key activities and events
Key activities and events Q1 2024 Offering and customers Sustainability and Quality • 510(k) for Hemopro 3, a new • Continued quality improvement efforts in Cardiac generation of our world-leading Assist and Cardiopulmonary endoscopic vessel harvesting ‒ CE mark temporarily suspended for Intra-Aorti
Slide 4: Organic order growth in all regions
Organic order growth in all regions Soft organic net sales in APAC mainly due to China Global Americas EMEA APAC +2.5% Organic Order Growth 0.0% Organic Net Sales Growth Getinge │ Presentation │ Q1 Report 2024 February 1, 2024
Slide 5: Outlook 2024: net sales expected to increase by 2-5% organically
Outlook 2024 Net sales for 2024 expected to increase by 2-5% organically (unchanged) Getinge │ Presentation │ Q1 Report 2024 February 1, 2024
Slide 6: Organic order growth in all business areas
Organic order growth in all business areas Order Intake Bridge Q1 2023 – Q1 2024 Organic change +1.3% +5.6% +3.6% +2.5% +7.8% 408 191 -17 8,059 7,476 MSEK Q1 2023 Acute Care Therapies Life Science Surgical Workflows Q1 2024 *CA: Cardiac Assist, CP: Cardiopulmonary Getinge │ Presentation │ Q1 Report
Slide 7: Healthy net sales contribution from acquisitions
Healthy net sales contribution from acquisitions Net Sales Bridge Q1 2023 – Q1 2024 Organic change +0.9% -9.2% +2.4% 0.0% +5.2% 369 -95 Currency impact, MSEK 29 2.3 -27 7,513 7,141 MSEK Organic growth, % Q1 2023 Acute Care Life Science Surgical Q1 2024 -4.1 Therapies Workflows Capital Recurring Good
Slide 8: Adj Gross Margin impacted by quality costs and inflation
Adj Gross Margin impacted by quality costs and inflation Adjusted Gross Profit Bridge Q1 2023 – Q1 2024 Adj GM, % Q1 2024 60.2 40.5 41.7 51.3 (Q1 2023) (61.6) (42.6) (39.5) (52.3) Gross Margin impact +3.3% 203 Product and Geo mix -73 -7 Supply, Absorption & Cost inflation MSEK 3,855 3,734 Price Curr
Slide 9: Adj EBITA margin negatively impacted by higher Adj OPEX
Adj EBITA margin negatively impacted by higher Adj OPEX Adjusted EBITA Bridge Q1 2023 – Q1 2024 13.6% 11.2% Margin development -1.2 pp Adj GP -13.4% -2.1 pp Adj OPEX 121 +0.6 pp FX +0.3 pp D&A +43 -156 40 -119 -12 -5 Currency impact, MSEK MSEK 972 842 Q1 2023 Adj Gross Adj Selling Adj Admin Adj R&D
Slide 10: Stable Free Cash Flow and Working Capital days below 100
Stable Free Cash Flow and Working Capital days below 100 Capital efficiency a priority Healthy Free Cash Flow WC days below 100 ROIC below trend, but still well above prepandemic levels 200 1.1 1.0 150 0.9 0.3 100 10.1% 7.5% -0.7 0 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q1 2019 Q1 2020 Q1 2021 Q1 2
Slide 11: Solid financial position
Solid financial position Margin of safety when it comes to net debt and leverage Net debt impacted by finalized acquisitions … … but leverage still signalling financial strength 14.0 3.4x 7.6 (5,0 BSEK excl. pension liabilities) 1.4x (0.9x excl. pension liabilities) Q1 2019 Q1 2020 Q1 2021 Q1 2022 Q
Slide 12: Summary
Summary Getinge │ Presentation │ Q1 Report 2024 February 1, 2024
Slide 13: Key takeaways
Key takeaways Summary Q1 2024 • Net sales increased by 5.2% whereof 0.0% organically and order intake grew by 7.8% whereof 2.5% organically • Reiterating our Outlook for 2024: net sales growth of 2-5% • Margins negatively impacted by quality related costs and higher costs for employees and input mat
Slide 14: Q&A
Q&A Getinge │ Presentation │ Q1 Report 2024 February 1, 2024
Slide 15: Thank you
Thank you Getinge │ Presentation │ Q1 Report 2024 February 1, 2024
Slide 16: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Slide 17: Getinge - Passion for Life
“~~ Se A GETINGE PASSION FOR LIFE